Evaluation of the therapeutic potential of combining VT464 and G1T38 in treatment-resistant prostate and breast cancer models
Research Grant
Administered By
Pharmacology & Cancer Biology
Awarded By
Innocrin Pharmaceutical, Inc.
Start Date
January 19, 2016
End Date
July 31, 2017
Administered By
Pharmacology & Cancer Biology
Awarded By
Innocrin Pharmaceutical, Inc.
Start Date
January 19, 2016
End Date
July 31, 2017